Urinary excretion of ipecac alkaloids in human volunteers

Veterinary and Human Toxicology

Volumn 44, Issue 5, 2002, Pages 257-259

  Yamashita, Masatomo ^a   Yamashita, Mamoru ^a   Azuma, Junichi ^a  

^a University of Tsukuba School of Medicine   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; CEPHAELINE; EMETINE; IPECAC;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NORMAL HUMAN; SYRUP; URINARY EXCRETION; VOMITING;

ADMINISTRATION, ORAL; ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EMETICS; EMETINE; HUMANS; IPECAC; MALE; VOMITING;

CEPHAELIS IPECACUANHA;

EID: 0036784942     PISSN: 01456296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Ellenhorn MJ: Ellenhorn's Medical Toxicology. Elsevier, New York: 66-78, 1997.
2. Manno BR, Manno JE: Toxicology of ipecac. Clin Toxicol 10: 221-242, 1977.
3. Dubick MA, Yang WCT: Metabolic effects of 9-day emetine treatment in rabbits. Toxicol Appl Pharmacol 54: 311-322, 1980.
4. Bradley WG, Fewings JD, Harris JB et al: Emetine myopathy in the rat. Br J Pharmacol 57: 29-41, 1976.
5. Smith RP, Smith DM: Acute ipecac poisoning: report of a fatal case and review of the literature. N Eng J Med 265: 523-525, 1961.
6. Adler AG, Walinsky P, Krall RA et al: Death resulting from ipecac syrup poisoning. JAMA 243: 1927-1928, 1980.
7. Brotman MC, Forbath N, Garfinkel PE et al: Myopathy due to ipecac syrup poisoning in a patient with anorexia nervosa. Can Med Assoc J 125: 453-454, 1981.
8. Sutphen JL, Saulsbury FT: Intentional ipecac poisoning: Munchausen syndrome by proxy. Pediatrics 82: 453-456, 1988.
9. McClung HJ, Murray R, Braden NJ et al: Intentional ipecac poisoning in children. Am J Dis Child 142: 637-639, 1988.
10. Schneider DJ, Perez A, Knilans TE et al: Experience and reason-briefly recorded. Pediatrics 97: 902-906, 1996.
11. Moran DM, Crouch DJ, Finkle BS: Absorption of ipecac alkaloids in emergency patients. Ann Emerg Med 13: 1100-1102, 1984.
12. Scharman EJ, Hutzler JM, Rosencrance JG et al: Single dose pharmacokinetics of syrup of ipecac. Ther Drug Monit 22: 566-573, 2000.
13. Asano T, Sadakane C, Ishihara K et al: High-performance liquid chromatographic assay with fluorescence detection for the determination of cephaeline and emetine in human plasma and urine. Biol Pharm Bull 24: 678-682, 2001.
14. Goodman LS, Gilman A: The Pharmacological Basis of Therapeutics, 5th Ed. MacMillan Publishing, New York: 1075-1080, 1975.
15. Carraccio, Blotny K, Ringel R: Sudden onset of profound weakness in toddler. J Pediatr 122: 663-667, 1993.
16. Lachman MF, Romeo R, McComb RB: Emetine identified in urine by HPLC, with fluorescence and ultraviolet/diode array detection, in a patient with cardiomyopathy. Clin Chem 35: 499-502, 1989.
17. Gimble AI, Davison C, Smith PK: Studies on the toxicity, distribution and excretion of emetine. J Pharmacol Exp Ther 94: 431-438, 1948.
18. Asano T, Ishihara K, Wakui Y et al: Absorption, distribution and excretion of 3H-labeled cephaeline- and emetine-spiked ipecac syrup in rats. Eur J Drug Metab Pharmacokinet 27: 17-21, 2002.
19. Kuling K, Bar-Or D, Cantrill SV et al: Management of acutely poisoned patients without gastric emptying. Ann Emerg Med 14: 562-567, 1985.
20. MacLeod J: Ipecac intoxication: use of a cardiac pacemaker in management. N Engl J Med 268: 146-147, 1963.
21. Weaver JE, Griffith JF: Induction of emesis by detergent ingredients and formulations. Toxicol Appl Pharmacol 14: 214-220, 1969.
22. Yamashita M, Yamashita M, Tanaka J et al: Vomiting induction by ipecac syrup in dogs and ferrets. J Toxicol Sci 22: 409-412, 1997.